Literature DB >> 3304906

Effects of intranasal insulin in non-obese type II diabetics.

A G Frauman, G Jerums, W J Louis.   

Abstract

The comparative effects of intranasal and subcutaneous insulin on blood glucose and insulin levels are described in non-obese type II diabetics, in the fasting state and following a standard meal. In the fasting studies, intranasal insulin (30 units) produced a single early insulin peak. Elevated insulin levels and their hypoglycaemic effect persisted for less than 2 h whereas with subcutaneous insulin (8 units) elevated insulin levels and evidence of hypoglycaemic action were still present at 4 h. By contrast, in the meal studies both forms of insulin had similar effects on serum insulin levels and blood glucose. Moreover elevated insulin levels and evidence of reduction in post-prandial hyperglycaemia were now present at 4 h with both intranasal and subcutaneous insulin administration. Intranasal insulin in combination with a test meal now produced a biphasic insulin profile more closely resembling the normal insulin response to a meal, and reflecting the combined effects of endogenous and exogenous insulin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3304906     DOI: 10.1016/s0168-8227(87)80039-6

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  7 in total

Review 1.  Nasal route and drug delivery systems.

Authors:  Selcan Türker; Erten Onur; Yekta Ozer
Journal:  Pharm World Sci       Date:  2004-06

2.  Intranasal insulin therapy: the clinical realities.

Authors:  J Hilsted; S Madsbad; A Hvidberg; M H Rasmussen; T Krarup; H Ipsen; B Hansen; M Pedersen; R Djurup; B Oxenbøll
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122

Review 3.  Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke.

Authors:  Vasileios-Arsenios Lioutas; Freddy Alfaro-Martinez; Francisco Bedoya; Chen-Chih Chung; Daniela A Pimentel; Vera Novak
Journal:  Transl Stroke Res       Date:  2015-06-05       Impact factor: 6.829

Review 4.  Intranasal insulin. Clinical pharmacokinetics.

Authors:  L Illum; S S Davis
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

Review 5.  Intranasal insulin in Alzheimer's dementia or mild cognitive impairment: a systematic review.

Authors:  Konstantinos Ioannis Avgerinos; Grigorios Kalaitzidis; Antonia Malli; Dimitrios Kalaitzoglou; Pavlos Gr Myserlis; Vasileios-Arsenios Lioutas
Journal:  J Neurol       Date:  2018-02-01       Impact factor: 4.849

Review 6.  Insulin in the nervous system and the mind: Functions in metabolism, memory, and mood.

Authors:  Seung-Hwan Lee; Janice M Zabolotny; Hu Huang; Hyon Lee; Young-Bum Kim
Journal:  Mol Metab       Date:  2016-06-29       Impact factor: 7.422

7.  Inhibitory Effects of Intranasal Administration of Insulin on Fat Oxidation during Exercise Are Diminished in Young Overweight Individuals.

Authors:  Hisayo Yokoyama; Ryosuke Takeda; Eriko Kawai; Akemi Ota; Emiko Morita; Daiki Imai; Yuta Suzuki; Tomoaki Morioka; Masanori Emoto; Masaaki Inaba; Kazunobu Okazaki
Journal:  J Clin Med       Date:  2018-09-28       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.